Axogen, Inc.
AXGN- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0000805928
In the last 90 days, Axogen, Inc. insiders filed 0 open-market purchases and 4 sales; 253 institutions reported holding it in 13F filings for Q2 2026, worth $2.43B in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Axogen, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 222 | 3 | 253 | +34 |
| Shares | 49.9M | 40.0K | 52.6M | +2.77M (+5.6%) |
| Value | $1.65B | $1.32M | $2.43B | +$778.9M (+47.2%) |
3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (52)
Institutions that held Axogen, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (18)
Institutions that held Axogen, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Parkman Healthcare Partners LLC | 268,160 | $8.88M |
| Sofinnova Investments, Inc. | 210,665 | $6.98M |
| Aquatic Capital Management LLC | 78,715 | $2.61M |
| Seven Grand Managers, LLC | 75,000 | $2.48M |
| Public Employees Retirement System of Ohio | 51,918 | $1.72M |
| Arrowpoint Investment Partners (Singapore) Pte. Ltd. | 16,273 | $539.1K |
| Diversified Trust Co | 12,998 | $430.6K |
| Centiva Capital, LP | 11,711 | $388.0K |
| Verdad Advisers, LP | 11,507 | $381.2K |
| Covalis Capital LLP | 10,000 | $331.3K |
| Voleon Capital Management LP | 9,279 | $307.4K |
| EntryPoint Capital, LLC | 7,336 | $243.0K |
| Advisory Services Network, LLC | 391 | $13.0K |
| Parallel Advisors, LLC | 92 | $3.05K |
| Quadrant Capital Group LLC | 66 | $2.19K |
| MAI Capital Management | 62 | $2.06K |
| Aster Capital Management (DIFC) Ltd | 98 | $1.81K |
| Root Financial Partners, LLC | 10 | $331 |
Not filed for Q2 2026 yet (3)
Institutions that held Axogen, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Skopos Labs, Inc. | 21,700 | $718.9K |
| Janus Henderson Group PLC | 18,100 | $600.2K |
| CWM, LLC | 160 | $5.30K |